Image

Direct Extubation Versus Extubation After a Spontaneous Breathing Trial in Patients at Low Risk of Extubation Failure

Direct Extubation Versus Extubation After a Spontaneous Breathing Trial in Patients at Low Risk of Extubation Failure

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

This randomized controlled open label trial aims at comparing a weaning strategy including a spontaneous breathing trial as a prerequisite for extubation to a weaning strategy without a spontaneous breathing trial (direct extubation) in patients with readiness to be weaned criteria and considered at low risk of extubation failure. The main endpoint will be the proportion of patients successfully extubated within the 24 hours after randomization as compared to extubation after a successful spontaneous breathing trial (SBT).

Description

Weaning from mechanical ventilation is a critical step in the course on an ICU stay. Separation from the ventilator should be done at the earliest possible time, but extubation failure is an adverse event that should be avoided. The most common decision-making strategy regarding weaning and extubation is to combine a daily assessment of the patient's "readiness to wean" and a spontaneous breathing trial before to extubate.

The result of the SBT (passed of failed) is often viewed as a "go - no go" indicator of whether or not patients are ready for extubation, but daily practice indicates that the assessment of the SBT is subjective with a frequent natural tendency for clinicians to keep their patients on the 'safe' side, i.e., considering them as not being ready for extubation. However, the results of the SBT should be interpreted based on the pre-test probability. Conducting a SBT in patients while the pre-test probability of success is high will result in false negatives which are likely to delay the decision of extubation. In addition, a pointless SBT may expose patients to anxiety, air hunger and dyspnea which are poorly detected by caregivers. The hypothesis of the present project is that in patients who are at low risk of extubation failure, a SBT is useless and once readiness to wean criteria are met, direct extubation would increase the proportion of patients successfully extubated within the 24 hours after randomization as compared to extubation after a successful SBT.

Eligibility

Inclusion Criteria:

  • Age older than 18 years and \< 65 years old
  • Nasal or oral intubation longer than 24 hours and less than 4 days
  • Satisfaction to each following weaning readiness criteria:
    1. Respiratory rate \< 35 cycles per minute
    2. SpO2 \>90% with FiO2\<40% and PEEP\<8 cmH2O
    3. RASS score between -2 and +2 with low level or no sedatives
    4. No need or low doses of vasopressors
    5. Adequate cough
  • Inform consent by patient or legal representative or the close relative or emergency inclusion procedure.

Exclusion Criteria:

  • Risk factor for extubation failure as defined by any of the following criteria:
    • Chronic cardiac disease (left ejection fraction below 45%, documented history of cardiogenic pulmonary edema, permanent atrial fibrillation).
    • Chronic respiratory disease (severe COPD, documented restricted lung disease or obesity-hypoventilation syndrome)
    • Body mass index \> 30 kg/m2
    • Airway patency problems, including high risk of developing laryngeal edema, inability to deal with respiratory secretions, brain injury, documented swallowing disorders
  • Tracheostomy
  • Underlying chronic neuromuscular disease
  • Do not resuscitate orders
  • Pregnant or lacting woman
  • Patient under guardianship
  • Patient without healthcare insurance
  • Refusal to participate and sign the written consent
  • Patients with traumatic brain injury
  • Post surgery patients
  • Patients included in another interventional trial that may have an impact on the evaluation criteria of the present study
  • Patient under AME

Study details
    Weaning From Mechanical Ventilation
    Extubation

NCT07019636

Assistance Publique - Hôpitaux de Paris

18 July 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.